EA2182 / DECREASE
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
Physician and Research Staff Educational Material
This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.
Patient Educational Material
Participating sites should note that the Central Institutional Review Board (CIRB) has approved this material.
Study Chair Jennifer Dorth, MD of Case Western Reserve University discusses EA2182, a clinical trial for patients with early-stage anal cancer.
Study Chair Jennifer Dorth, MD of Case Western Reserve University describes how anal cancer treatment has changed since the 1970s.